Diversify Wealth Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.13M Buy
20,054
+12,198
+155% +$1.83M 0.05% 279
2026
Q1
$1.12M Buy
+7,856
New +$1.2M 0.02% 566
2025
Q1
– Sell
-7,240
Closed -$717K – 540
2024
Q4
$717K Buy
7,240
+1,072
+17% +$114K 0.06% 274
2024
Q3
$704K Buy
+6,168
New +$700K 0.07% 240

Other funds holding NVS

Diversify Wealth Management's NVS Position: Q2 2026 in Review

Diversify Wealth Management increased its Novartis (NVS) stake by 155% in Q2 2026, buying an estimated $1.83M and bringing the position to 20,054 shares worth $3.13M. The position accounts for 0.05% of the portfolio, ranked #279.

Diversify Wealth Management first reported a position in NVS in Q3 2024 and has held it in 4 quarters since. 1,625 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Diversify Wealth Management held 20,054 shares of Novartis worth $3.13M as of Q2 2026.
  • Diversify Wealth Management bought 12,198 Novartis shares in Q2 2026, an estimated $1.83M.
  • Novartis made up 0.05% of Diversify Wealth Management's portfolio in Q2 2026, its #279 holding.
  • Diversify Wealth Management first reported a position in Novartis in Q3 2024 and has held it in 4 quarters since.
  • 1,625 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Diversify Wealth Management's 13F filing for Q2 2026, filed 30 Jul 2026.